Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Wei-Jie Guan1,2, Wen-Hua Liang3,2, Yi Zhao3,2

  • 1State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.

Insights

Patients with COVID-19 and comorbidities face higher risks of severe outcomes like ICU admission or death. Having multiple comorbidities significantly increases these risks, highlighting the importance of managing underlying health conditions.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic presents a rapidly evolving global health crisis.
  • Understanding risk factors for severe outcomes in COVID-19 patients is crucial for clinical management.
  • Comorbidities are suspected to influence COVID-19 patient prognosis.

Purpose of the Study:

  • To assess the risk of severe adverse outcomes in COVID-19 patients.
  • To stratify risk based on the presence and number of comorbidities.
  • To identify specific comorbidities associated with poor clinical outcomes.

Main Methods:

  • Analysis of data from 1590 hospitalized COVID-19 patients in China.
  • Inclusion of composite endpoints: ICU admission, invasive ventilation, or death.
  • Comparison of composite endpoint risk based on comorbidity status (none, one, or multiple).

Main Results:

  • 16.0% of patients had severe cases; 8.2% reached composite endpoints.
  • Hypertension (16.9%) and diabetes (8.2%) were the most common comorbidities.
  • COPD, diabetes, hypertension, and malignancy were significant risk factors for severe outcomes.

Conclusions:

  • COVID-19 patients with any comorbidity experience worse clinical outcomes.
  • An increasing number of comorbidities correlates with poorer prognosis.
  • Comorbidity status is a critical determinant of COVID-19 severity and patient outcomes.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.9K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.4K